Price T Rowe Associates Inc Relay Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

  • $883 Billion
  • Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,875,936 shares of RLAY stock, worth $9.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,875,936
Previous 3,477,791 17.31%
Holding current value
$9.63 Million
Previous $9.11 Million 9.21%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$2.0 - $3.49 $1.2 Million - $2.1 Million
-601,855 Reduced 17.31%
2,875,936 $9.95 Million
Q1 2025

May 14, 2025
BUY
$2.62 - $4.92 $408,851 - $767,766
156,050 Added 4.7%
3,477,791 $9.11 Million
Q4 2024

Feb 14, 2025
SELL
$4.12 - $6.8 $8.07 Million - $13.3 Million
-1,958,550 Reduced 37.09%
3,321,741 $13.7 Million
Q3 2024

Nov 14, 2024
BUY
$6.23 - $9.51 $1.5 Million - $2.29 Million
241,276 Added 4.79%
5,280,291 $37.4 Million
Q2 2024

Aug 14, 2024
SELL
$5.9 - $8.02 $10.9 Million - $14.8 Million
-1,840,582 Reduced 26.75%
5,039,015 $32.9 Million
Q1 2024

May 15, 2024
SELL
$7.5 - $12.07 $12.8 Million - $20.5 Million
-1,701,570 Reduced 19.83%
6,879,597 $57.1 Million
Q4 2023

Feb 14, 2024
SELL
$6.01 - $11.48 $166,951 - $318,902
-27,779 Reduced 0.32%
8,581,167 $94.5 Million
Q3 2023

Nov 14, 2023
BUY
$8.24 - $12.97 $2.17 Million - $3.42 Million
263,429 Added 3.16%
8,608,946 $72.4 Million
Q2 2023

Aug 14, 2023
BUY
$9.99 - $18.27 $14.8 Million - $27.1 Million
1,482,557 Added 21.6%
8,345,517 $105 Million
Q1 2023

May 15, 2023
BUY
$15.0 - $22.76 $35.5 Million - $53.9 Million
2,369,956 Added 52.75%
6,862,960 $113 Million
Q4 2022

Feb 14, 2023
SELL
$14.16 - $24.02 $967,963 - $1.64 Million
-68,359 Reduced 1.5%
4,493,004 $67.1 Million
Q3 2022

Nov 14, 2022
SELL
$18.07 - $31.37 $13.4 Million - $23.2 Million
-738,944 Reduced 13.94%
4,561,363 $102 Million
Q2 2022

Aug 15, 2022
BUY
$13.31 - $34.88 $4 Million - $10.5 Million
300,589 Added 6.01%
5,300,307 $88.8 Million
Q1 2022

May 16, 2022
BUY
$20.26 - $32.36 $17.1 Million - $27.3 Million
844,377 Added 20.32%
4,999,718 $150 Million
Q4 2021

Feb 14, 2022
BUY
$26.0 - $37.03 $66 Million - $94 Million
2,537,388 Added 156.83%
4,155,341 $128 Million
Q3 2021

Nov 15, 2021
BUY
$29.75 - $37.99 $13.2 Million - $16.9 Million
444,471 Added 37.88%
1,617,953 $51 Million
Q2 2021

Aug 16, 2021
SELL
$27.5 - $38.19 $9.12 Million - $12.7 Million
-331,610 Reduced 22.03%
1,173,482 $42.9 Million
Q1 2021

May 17, 2021
BUY
$32.52 - $61.53 $23.8 Million - $45 Million
731,517 Added 94.56%
1,505,092 $52 Million
Q4 2020

Feb 16, 2021
BUY
$35.51 - $54.03 $27.5 Million - $41.8 Million
773,575 New
773,575 $32.2 Million

Others Institutions Holding RLAY

# of Institutions
213
Shares Held
172M
Call Options Held
0
Put Options Held
36.1K
View Full List

About Relay Therapeutics, Inc.

RLAY Quotes by TradingView
  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $403M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email